First Time Loading...
B

Betta Pharmaceuticals Co Ltd
SZSE:300558

Watchlist Manager
Betta Pharmaceuticals Co Ltd
SZSE:300558
Watchlist
Price: 38.38 CNY 2.29%
Updated: Jun 5, 2024

Betta Pharmaceuticals Co Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Betta Pharmaceuticals Co Ltd
Operating Income Peer Comparison

Comparables:
H
3692
600436
600276
000538
S
688506

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
B
Betta Pharmaceuticals Co Ltd
SZSE:300558
Operating Income
¥421.7m
CAGR 3-Years
-1%
CAGR 5-Years
15%
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Operating Income
¥2.6B
CAGR 3-Years
-2%
CAGR 5-Years
3%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Operating Income
¥3.5B
CAGR 3-Years
21%
CAGR 5-Years
22%
CAGR 10-Years
22%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Operating Income
¥4.8B
CAGR 3-Years
-10%
CAGR 5-Years
1%
CAGR 10-Years
12%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Operating Income
¥3.9B
CAGR 3-Years
-3%
CAGR 5-Years
6%
CAGR 10-Years
4%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Operating Income
-¥749.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Betta Pharmaceuticals Co Ltd's Operating Income?
Operating Income
421.7m CNY

Based on the financial report for Mar 31, 2024, Betta Pharmaceuticals Co Ltd's Operating Income amounts to 421.7m CNY.

What is Betta Pharmaceuticals Co Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
15%

Over the last year, the Operating Income growth was 233%. The average annual Operating Income growth rates for Betta Pharmaceuticals Co Ltd have been -1% over the past three years , 15% over the past five years .